Precipio Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Precipio.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth20.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost

Aug 21
Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

Jun 07
Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet

Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)

Mar 29
Investors Holding Back On Precipio, Inc. (NASDAQ:PRPO)

Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity

Aug 29
Precipio, Inc.'s (NASDAQ:PRPO) Subdued P/S Might Signal An Opportunity

Precipio to distribute HemeScreen through Fisher Healthcare channel

Jul 20

Precipio terminates its equity line with Lincoln Park

Jun 15

We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation

Jun 12
We Think Some Shareholders May Hesitate To Increase Precipio, Inc.'s (NASDAQ:PRPO) CEO Compensation

Precipio shares surge on HemeScreen Anemia Panel launch

Jun 08

Precipio shares surge on launching hemescreen panel for Acute Myeloid Leukemia

May 10

Precipio: COVID-19 Testing At Amazon Is An Impressive Yet Transitory Fluke

May 05

Precipio shares jump on launching its rapid COVID-19 antibody test on Amazon platform

May 03

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Precipio has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:PRPO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202417-300N/A
6/30/202417-4-1-1N/A
3/31/202416-5-3-3N/A
12/31/202315-6-4-4N/A
9/30/202313-9-5-5N/A
6/30/202311-11-7-7N/A
3/31/202310-11-7-7N/A
12/31/20229-12-8-8N/A
9/30/20229-12-8-8N/A
6/30/20229-11-8-8N/A
3/31/20229-12-8-8N/A
12/31/20219-9-7-7N/A
9/30/20218-8-7-7N/A
6/30/20218-10-7-7N/A
3/31/20217-9-7-7N/A
12/31/20206-14-8-7N/A
9/30/20205-16-8-8N/A
6/30/20204-14-8-8N/A
3/31/20204-18-9-9N/A
12/31/20193-13-9-9N/A
9/30/20193-16-9-9N/A
6/30/20193-18-8-8N/A
3/31/20193-16-8-7N/A
12/31/20183-20-7-7N/A
9/30/20183-26-7-7N/A
6/30/20183-33N/A-9N/A
3/31/20182-38N/A-8N/A
12/31/20172-33N/A-7N/A
9/30/20171-21N/A-5N/A
6/30/20171-11N/A-1N/A
3/31/20171-3N/A-1N/A
12/31/20162-4N/A-1N/A
12/31/20151-2N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PRPO's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if PRPO's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if PRPO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PRPO's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if PRPO's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if PRPO's Return on Equity is forecast to be high in 3 years time


Discover growth companies